“pHLIP Inc. acts as a molecular nanosyringe, inserting itself into the cell membrane and injecting compounds into cells,” said co-founder, president, and URI Professor Yana Reshetnyak.
What: Healthcare startup
Innovation: Nanotechnology platform for highly sensitive cancer imaging and treatment.
Who: URI professors Oleg Andreev and Yana Reshetnyak, and Yale University professor Donald Engelman
Market: Cancer treatment, including breast, prostate, bladder, melanoma, lymphoma, pancreatic, lung, ovarian, and brain.
Idea: Enable targeted delivery of therapeutic, diagnostic, prophylactic, and research agents to cells in diseased acidic tissues, including cancers, ischemic myocardium, inflammatory arthritis, and stroke.
Notes: Licensed technology to URI startup Optera Diagnostics.